Bevacizumab (Avegra®) for the treatment of gynecological cancers: joint experience of several centers
Tumors of the female reproductive system are among the five most common cancers in women worldwide. Up to 60 % of these patients require chemotherapy to reduce the risk of recurrence. Currently, an additional treatment option is available for patients with advanced cancers of the female reproductive...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2021-03-01
|
| Series: | Opuholi Ženskoj Reproduktivnoj Sistemy |
| Subjects: | |
| Online Access: | https://ojrs.abvpress.ru/ojrs/article/view/781 |